H3D, Inc. was launched in 2011 by University of Michigan professor Zhong He and three of his former students after they developed a new gamma-ray detector technology supported by funds from the Defense Threat Reduction Agency, as well as the Department of Homeland Security. H3D’s innovative technology has been used by the Department of Defense, Federal Bureau of Investigation, Department of Energy, and International Atomic Energy Agency. H3D’s gamma-ray sensors are currently used in more than 75% of nuclear power plants across the United States, ensuring that America’s power plant workers are ensuring the safety of America’s power plant workers.
HistoSonics was founded in 2009 after Professor Zhen Xu, along with a group of researchers at the University of Michigan Schools of Engineering and Medicine, discovered the efficacy of histotripsy, a technique allowing ultrasounds to penetrate and destroy tumors in liver cancer patients. Supported by federal grants from the National Institutes of Health and VA Merit Review, HistoSonics research received FDA approval for its innovation, the Edison Histotripsy System, in 2023. The Edison utilizes histotripsy to provide a non-invasive option for treating patients with liver tumors.